CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.08
−3.77%Leverage
- Debt / equity
- 3.81x
- Net debt / equity
- -3.72x
- Debt / assets
- 0.29x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 0.09x
Liquidity & coverage
- Current ratio
- 1.25x
- Quick ratio
- 1.25x
- Cash ratio
- 0.82x
- Interest coverage
- -730.70x
- EBITDA / interest
- -709.17x
- Working capital
- $5.4M
Cash & dividend
- FCF / debt
- -5.70x
- Cash flow / debt
- -5.68x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026